Influx Healthtech (NSE:INFLUX) Marketable Securities: ₹23 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INFLUX Influx Healthtech Ltd NSE:INFLUX
22 GF Score
Price ₹293.35
! 4 Warning Signs
View Full Analysis

What is Influx Healthtech Marketable Securities?

Influx Healthtech NSE:INFLUX -3.10% 22 Marketable Securities is ₹23 Mil as of Mar. 2026. GuruFocus rates NSE:INFLUX with a GF Score™ of 22/100. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Influx Healthtech's Marketable Securities for the quarter that ended in Mar. 2026 was ₹23 Mil.

Influx Healthtech's annual Marketable Securities stayed the same from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil) but then increased from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹23 Mil).

Influx Healthtech  (NSE:INFLUX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Influx Healthtech Marketable Securities Related Terms

Influx Healthtech Marketable Securities Historical Data

* Premium members only.

The historical data trend for Influx Healthtech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Influx Healthtech Marketable Securities Chart

Influx Healthtech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
0.00 0.00 0.00 0.00 23.00

Influx Healthtech Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Marketable Securities Get a 7-Day Free Trial 0.00 0.00 0.00 336.83 23.00
NSE:INFLUX
22GF Score
Influx Healthtech Ltd NSE:INFLUX
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Influx Healthtech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹23 Mil mean?
Influx Healthtech (NSE:INFLUX) has a Marketable Securities of ₹23 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Influx Healthtech and its competitors.
Is Influx Healthtech's Marketable Securities too high?
Influx Healthtech's current Marketable Securities is ₹23 Mil. Overall, Influx Healthtech has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's Marketable Securities compare to ZTS?
Influx Healthtech's Marketable Securities of ₹23 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Influx Healthtech and its competitors. Influx Healthtech's current Marketable Securities is ₹23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current Marketable Securities of ₹23 Mil. The current Marketable Securities is ₹23 Mil. Influx Healthtech's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current Marketable Securities is ₹23 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Influx Healthtech Business Description

Address Plot No. 856, 109, Ghanshyam Enclave Premises Co-op Society, Behind Laljipada Police Chowky, Kandivali West, Mumbai, MH, IND, 400067
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
22GF Score

Get the complete analysis for NSE:INFLUX

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹293.35
Price